Connect with us

Technology

Sobi Q3 2024 report: Strong growth and significant pipeline momentum

Published

on

STOCKHOLM, Oct. 24, 2024 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the third quarter 2024

Third Quarter 2024

Total revenue increased 33 per cent, 39 per cent at constant exchange rates, (CER)1, to SEK 6,894 M (5,168)Haematology revenue increased 18 per cent at CER to SEK 4,000 M (3,484), mainly driven by strong sales of Doptelet® of SEK 1,039 M (650), sales of Aspaveli®/Empaveli® of SEK 270 M (169) and launch sales of Altuvoct® of SEK 129 M (—)Immunology revenue increased 96 per cent at CER to SEK 2,583 M (1,400), driven by strong Beyfortus® royalty of SEK 1,478 M (263) and sales of Kineret® of SEK 699 M (600)Revenue from medicines in the strategic portfolio* grew by 113 per cent at CER to SEK 3,830 M (1,924)The adjusted EBITA margin1,2 was 43 per cent (30), excluding items affecting comparability (IAC)2. EBITA was SEK 2,923 M (1,443), corresponding to a margin of 42 per cent (28). EBIT was SEK 2,038 M (547)Earnings per share (EPS) before dilution was SEK 4.27 (0.30). Adjusted EPS before dilution1 was SEK 4.36 (0.54). Cash flow from operating activities was SEK 1,201 M (1,058)In August, Sobi and Apellis Pharmaceuticals announced positive topline results from the Phase 3 VALIANT study of pegcetacoplan in C3G and primary IC-MPGN

Outlook 2024 – Updated

Revenue is anticipated to grow by a mid-teens percentage at CER (previously low double-digit)The adjusted EBITA margin is anticipated to be in the mid-30s percentage of revenue (unchanged)

Click here for the Financial Summary.

Alternative Performance Measures (APMs).Items affecting comparability (IAC).

* The strategic portfolio includes Sobi’s medicines Altuvoct, Aspaveli/Empaveli, Doptelet, Gamifant®, Vonjo® and Zynlonta®, and royalty on Sanofi’s sales of Altuviiio® and Beyfortus.

Investors, analysts, and the media are invited to a conference call on the same day at 14:00 CEST, 13:00 BST, and 08:00 EDT. The call will include a presentation of the results and a Q&A session.

The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com before the conference call.

To participate in the conference call, please use the following dial-in details:
Sweden: +46 8 5051 0031
United Kingdom: +44 207 107 06 13
United States: +1 631 570 56 13

For other countries, please find the details here.

Sobi

Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Providing reliable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 1,800 employees across Europe, North America, the Middle East, Asia and Australia. In 2023, revenue amounted to SEK 22.1 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.

For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media contacts, click here.

This information is information that Sobi is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08:00 CEST on 24 October 2024.

Gerard Tobin

Head of Investor Relations

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/swedish-orphan-biovitrum-ab/r/sobi-q3-2024-report–strong-growth-and-significant-pipeline-momentum,c4055499

The following files are available for download:

https://mb.cision.com/Main/14266/4055499/3071945.pdf

Q3 2024 report. Strong growth and significant pipeline momentum

 

View original content:https://www.prnewswire.co.uk/news-releases/sobi-q3-2024-report-strong-growth-and-significant-pipeline-momentum-302285671.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Fox ESS Celebrates Strong Momentum with Integrated Solar Storage & Charging Solutions at Smart Energy 2026

Published

on

By

SYDNEY, May 9, 2026 /PRNewswire/ — Fox ESS, a global leader in renewable energy solutions, attended Smart Energy 2026 during 6-7 May as a platinum sponsor. At the event, Fox ESS showcased its next-generation approach to solar storage and EV charging solution, delivering a seamless, future-ready energy experience for homeowners and installers across Australia.

Integrated Solutions Tailored for Aussie Homes

At Smart Energy 2026, Fox ESS highlighted its storage-to-charging solution, designed to make everyday energy use more convenient for local residents. With performance-led products and proven market traction, Fox ESS is set to play its part in building a more resilient energy future for Australia.

Battery Systems

Fox ESS continues to build momentum in the battery market. Sunwiz, an Australian solar consultancy, recently reported that Fox ESS ranked No.1 in March for installation capacity. And the company also revealed it has installed more than 25,000 systems in April. During the exhibition, Sunwiz presented Fox ESS with an award, recognising the company as Top Solar Company for Fastest Growing Battery.

CQ7 V6+ High Voltage Battery (42kWh and above)
Building on Fox ESS’ proven strengths, compact design and high capacity, CQ7 V6+ is well suited to medium-sized households and ensure the free use of electricity and maximize the self-consumption.EQ4800 High Voltage Battery (28kWh)
A reliable choice for smaller households, designed for efficient day-to-day energy storage.

Alongside its battery range, Fox ESS showcased all-in-one systems, including Stackable AIO and EVO, designed to simplify installation while maintaining a high standard of design and presentation.

Inverters

Fox ESS offers a range of inverters to suit local requirements, supported by up to 200% PV oversizing and a 10-year product warranty.

Single-phase: H1‑G2 (3–6kW); KH series (7–10.5kW)Three-phase: H3 Smart (5–15kW); H3 Pro (15–29.9kW); H3 Plus (50–125kW)

EV Chargers

With EV adoption accelerating, Fox ESS also offers EV charging solutions with solar linkage, designed to work across its inverter portfolio. The chargers provide robust, smart energy management, including dynamic load balancing to help protect home circuits.

A Series (7.3kW / 11kW / 22kW): IP65 and IK08 protection, OCPP-compliant.L Series (7.3kW / 11kW): straightforward installation with multiple colour options.

Big Battery Still Takes Centre Stage

As the Cheaper Home Battery Program moves into a new phase under an updated rebate policy, interest in larger battery systems continues to grow, particularly as more households consider EV upgrades amid rising fuel costs. More EVs typically mean households need greater energy availability, making higher-capacity storage an increasingly attractive option.

Looking ahead, from 1 July 2026, the Australian Government’s Solar Sharer Offer (SSO) will provide eligible households with three hours of free daily electricity to align with peak solar generation. Households with larger batteries will be well placed to make the most of this opportunity.

Fox ESS is also working with local VPP partners, including Amber Electric and Origin Loop VPP, helping homeowners unlock maximum value while supporting greater grid stability.

Maimai Comes Alive at the Exhibition

Visitors to the Fox ESS stand experienced a full programme of brand activations across the event. Following the online announcement, Sydney served as Maimai’s first physical stop, bringing the community together for face-to-face engagement. Attendees queued to take photos with the brand’s friendly and recognisable mascot.

Long-Term Commitment to Australia

Fox ESS has opened two local offices in Melbourne and Sydney, with more than 30 dedicated specialists supporting local customer needs. The company is also looking to play a wider role in Australia’s energy transition.

Notably, Ian Thorpe made his first in-person appearance at Fox Night, where he presented partners with awards. At the event party, Fox ESS also hosted a battery installation challenge, featuring eight rounds of competition, with the final winners receiving a range of prizes.

“We’re delighted to see such a strong result following the rollout of local policy. With nearly 400,000 Australian households now installing batteries, Fox ESS has played a key role, but this is only the beginning. We’re committed to keeping momentum and helping make a smarter, more reliable energy future a reality for more homes.” said Brooks Richard Geng, APAC & Middle East Managing Director, Fox ESS.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/fox-ess-celebrates-strong-momentum-with-integrated-solar-storage–charging-solutions-at-smart-energy-2026-302767429.html

SOURCE Fox ESS

Continue Reading

Technology

TELUS announces election of directors

Published

on

By

VANCOUVER, BC, May 8, 2026 /CNW/ – TELUS Corporation (TELUS) (TSX: T) (NYSE: TU) announced today that the nominees listed in TELUS’ 2026 information circular were elected as directors of TELUS. The detailed results of the vote for the election of directors held at TELUS’ annual meeting on May 8, 2026 (the Meeting) are set out below.

Each of the following 14 nominees proposed by management was elected as a director of TELUS:

Nominee

Votes For  

% Votes For  

Votes Withheld  

% Votes Withheld 

Raymond T. Chan

592,322,965

97.91

12,667,245

2.09

Hazel Claxton

599,400,953

99.08

5,589,256

0.92

Lisa De Wilde

583,361,107

96.42

21,629,103

3.58

Victor Dodig

593,352,117

98.08

11,638,092

1.92

Darren Entwistle

586,791,970

96.99

18,198,239

3.01

Thomas Flynn

596,684,564

98.63

8,305,646

1.37

Mary Jo Haddad

577,841,419

95.51

27,148,791

4.49

Martha Hall Findlay     

595,075,545

98.36

9,914,665

1.64

Christine Magee

597,282,615

98.73

7,707,595

1.27

John Manley

579,845,538

95.84

25,144,672

4.16

David Mowat

592,867,380

98.00

12,122,830

2.00

Marc Parent

577,961,748

95.53

27,028,461

4.47

Denise Pickett

596,211,746

98.55

8,778,464

1.45

W. Sean Willy

595,898,668

98.50

9,091,541

1.50

Final voting results on all matters voted on at the Meeting will be published shortly on telus.com/agm, and filed with the Canadian and U.S. securities regulators.

About TELUS

TELUS (TSX: T, NYSE: TU) is a world-leading communications technology company operating in more than 45 countries and generating over $20 billion in annual revenue with more than 21 million customer connections through our advanced suite of broadband services for consumers, businesses and the public sector. We are committed to leveraging our technology to enable remarkable human outcomes. TELUS is passionate about putting our customers and communities first, leading the way globally in client service excellence and social capitalism. TELUS Health is enhancing approximately 170 million lives across 200 countries and territories through innovative preventive medicine and well-being technologies. TELUS Agriculture & Consumer Goods utilizes digital technologies and data insights to optimize the connection between producers and consumers. TELUS Digital specializes in digital customer experiences and future-focused digital transformations that deliver value for their global clients. Guided by our enduring ‘give where we live’ philosophy, TELUS continues to invest in initiatives that support education, health and community well-being. In 2023, we launched the TELUS Student Bursary, which strives to ensure that every young person in Canada who wants a postsecondary education has the opportunity to pursue one. To date, the program has distributed over $6 million in bursaries to 2,000 students and counting. Since 2000, TELUS, our team members and retirees have contributed $1.85 billion in cash, in-kind contributions, time and programs, including 2.5 million days of service–earning TELUS the distinction of the world’s most giving company.

For more information, visit telus.com or follow @Darren_Entwistle on Instagram.

For more information, please contact:

Jacinthe Beaulieu
TELUS Media Relations
Jacinthe.Beaulieu@telus.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/telus-announces-election-of-directors-302767404.html

SOURCE TELUS Communications Inc.

Continue Reading

Technology

CTK BIO SELECTED TO PARTICIPATE IN NGEN’S $62.7M ADVANCED MANUFACTURING INITIATIVE

Published

on

By

VANCOUVER, BC, May 8, 2026 /CNW/ – CTK Bio Canada today announced its selection as a participant in a Next Generation Manufacturing Canada (NGen)-supported advanced manufacturing project, part of a $62.7 million national initiative backing 14 high-impact projects across Canada.

The initiative, recently announced by NGen, represents one of Canada’s most significant investments in advanced manufacturing, supporting collaborations between leading industry and technology partners to accelerate commercialization and strengthen global competitiveness. NGen’s project selection process is highly competitive, prioritizing initiatives with strong technical innovation, commercialization potential, and industry impact.

CTK Bio will contribute to the project titled “Streamlining Cosmetics Packaging with AI Powered Materials Informatics,” which uses artificial intelligence to guide the formulation and validation of packaging materials, ensuring compatibility with cosmetic products while meeting performance and regulatory requirements.

ADVANCING AI-DRIVEN MATERIALS INNOVATION
Through this project, CTK Bio is advancing an AI-powered materials informatics approach that improves how packaging materials are formulated, validated, and scaled for cosmetic applications.

By shifting from traditional trial-and-error methods to predictive, data-driven formulation, CTK Bio aims to:

Increase the success rate of new material developmentReduce formulation and validation timelinesLower development costsAccelerate commercialization of innovative and sustainable packaging solutions

EXECUTIVE COMMENTARY
JK Park, CEO
“This project unlocks synergies between CTK Bio and CTK Clip, where we already have an established global presence in the cosmetics market. By combining advanced materials innovation with existing market access, we can accelerate the commercialization of next-generation packaging solutions.”

ABOUT CTK BIO
CTK Bio Canada is focused on advancing next-generation biomaterials and manufacturing technologies, developing innovative solutions that enable more efficient, sustainable, and scalable production across global industries.

ABOUT NGEN
Next Generation Manufacturing Canada (NGen) is the industry-led organization spearheading Canada’s Global Innovation Cluster for Advanced Manufacturing. NGen brings together industry, academia, and technology partners to drive innovation, accelerate commercialization, and enhance Canada’s global competitiveness.

SOCIAL MEDIA ACCOUNTS:
Instagram: https://www.instagram.com/ctkbiocanada
Facebook: https://www.facebook.com/ctkbiocanada
LinkedIn: https://www.linkedin.com/company/ctk-bio-canada

For more information, visit www.ctkbio.com or call (604) 372-4200.

SOURCE CTK Bio

Continue Reading

Trending